TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23611569

Group type: EXPERIMENTAL
Intervention: Vilazodone 10, 20, 40, 60, and 80 mg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vilazodone
Number of subjects: 100
Study: 21950147

Group type: EXPERIMENTAL
Intervention: Test product (delayed release divalproex sodium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference product (delayed release divalproex sodium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of test and reference products
Number of subjects: 0
Study: 17660177

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.1 microg/kg combined with propofol 1 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Remifentanil 0.1 microg/kg combined with midazolam 0.05 mg/kg
Number of subjects: 60
Study: 16101707

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 microg.kg(‐1) IV
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11833836

Group type: EXPERIMENTAL
Intervention: Clinafloxacin 200 mg IV every 12 hours
Number of subjects: 84

Group type: COMPARATOR
Intervention: Piperacillin/tazobactam 3.375 g IV every 6 hours
Number of subjects: 84
Study: 10511931

Group type: EXPERIMENTAL
Intervention: AK incisions with collagen implants
Number of subjects: 8

Group type: COMPARATOR
Intervention: AK incisions without collagen implants (Control)
Number of subjects: 8
Study: 7856671

Group type: EXPERIMENTAL
Intervention: Oxygen therapy (10 L/min by face mask)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Oxygen therapy for ≤ 10 minutes
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Oxygen therapy for > 10 minutes
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study: 1950214

Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group without antibiotic prophylaxis
Number of subjects: 0
Study: 7042092

Group type: EXPERIMENTAL
Intervention: IF radiotherapy plus MOPP chemotherapy
Number of subjects: 305

Group type: COMPARATOR
Intervention: EF radiotherapy
Number of subjects: 305

Group type: COMPARATOR
Intervention: IF radiotherapy
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 305
Study: 31922265

Group type: EXPERIMENTAL
Intervention: Digene Hybrid Capture 2 HPV test with LBC
Number of subjects: 15955
Study: 30554882

Group type: EXPERIMENTAL
Intervention: BNO 1030 (Imupret®) as a supplement to standard symptomatic therapy
Number of subjects: 238

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 238
Study: 26575144

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg/kg bolus followed by 0.2 to 0.7 μg/kg/h infusion)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Propofol (25 to 50 μg/kg/min infusion)
Number of subjects: 183
Study: 25123162

Group type: EXPERIMENTAL
Intervention: Multiple courses of antenatal corticosteroids (ACS) therapy
Number of subjects: 1719

Group type: COMPARATOR
Intervention: Single course of antenatal corticosteroids (ACS) therapy
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Gestational age at birth
Number of subjects: 1719

Group type: EXPERIMENTAL
Intervention: Interaction between ACS groups and gestational age at birth
Number of subjects: 1719
Study: 22757662

Group type: EXPERIMENTAL
Intervention: Sodium picosulphate (Picoprep) bowel preparation
Number of subjects: 104
Study: 19201016

Group type: EXPERIMENTAL
Intervention: 5 mg of desloratadine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20 mg of desloratadine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17654322

Group type: EXPERIMENTAL
Intervention: Pre-dialytic endurance training on an ergometer three times a week for one year
Number of subjects: 55
Study: 16141777

Group type: EXPERIMENTAL
Intervention: Caring-based nursing intervention
Number of subjects: 0
Study: 12164403

Group type: EXPERIMENTAL
Intervention: Phlogenzym (bromelain 90 mg, trypsin 48 mg, rutin 100 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phlogenzym
Number of subjects: 60
Study: 10442597

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Minimal enteral feeding (3% to 24% of total calorie intake)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Not applicable (patients not receiving TPN)
Number of subjects: 60
Study: 7812574

Group type: EXPERIMENTAL
Intervention: salmeterol (50 micrograms twice daily)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: salbutamol (200 micrograms four times a day)
Number of subjects: 140

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study: 1972797

Group type: EXPERIMENTAL
Intervention: 50 micrograms dexmedetomidine (MPV‐1440), a selective alpha 2‐adrenoceptor agonist
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 100 mg atipamezole (MPV‐1248), a selective alpha 2‐adrenoceptor antagonist
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 11
Study: 74569

Group type: EXPERIMENTAL
Intervention: Upright group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Recumbent group
Number of subjects: 40
Study: 31475470

Group type: EXPERIMENTAL
Intervention: Combination therapy with non‐ablative fractional laser and intralesional steroid injection (1550‐nm erbium‐glass fractional laser treatment)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Combination therapy with non‐ablative fractional laser and intralesional steroid injection
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (steroid injection alone)
Number of subjects: 38
Study: 29451326

Group type: EXPERIMENTAL
Intervention: Partial breastfeeding
Number of subjects: 69159

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 69159

Group type: EXPERIMENTAL
Intervention: Prenatal intention to breastfeed
Number of subjects: 69159
Study: 27303788

Group type: EXPERIMENTAL
Intervention: S-1 (≥77.6 mg/m2/day)
Number of subjects: 111

Group type: COMPARATOR
Intervention: S-1 (≤65.9 mg/m2/day)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: GS (≥65.1 mg/m2/day)
Number of subjects: 111

Group type: COMPARATOR
Intervention: GS (≤53.8 mg/m2/day)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: S-1 (top 10% group)
Number of subjects: 111

Group type: COMPARATOR
Intervention: S-1 (bottom 10% group)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: GS (top 10% group)
Number of subjects: 111

Group type: COMPARATOR
Intervention: GS (bottom 10% group)
Number of subjects: 111
Study: 24575717

Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study: 23118932

Group type: EXPERIMENTAL
Intervention: GTP (500 mg daily)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: TC (60-minute group exercise, 3 times/week)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: GTP (500 mg daily) + TC (60-minute group exercise, 3 times/week)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 21048953

Group type: EXPERIMENTAL
Intervention: Recombinant replication-defective adenovirus type 5 (rAd5) vaccine expressing HIV-1 Gag, Pol, and multiclade Env proteins, VRC-HIVADV014-00-VP, at a dose of 10^10 or 10^11 adenovector particle units
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Recombinant replication-defective adenovirus type 5 (rAd5) vaccine
Number of subjects: 87
Study: 16956709

Group type: EXPERIMENTAL
Intervention: Polyacid-modified resin composite/resin composite open sandwich technique
Number of subjects: 57

Group type: COMPARATOR
Intervention: Direct resin composite restoration
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 57
Study: 15969949

Group type: EXPERIMENTAL
Intervention: Rapidly disintegrating stanol lecithin tablets (1.26 g stanols daily)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Slowly disintegrating capsules (1.01 g daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 12324640

Group type: EXPERIMENTAL
Intervention: Polynutrient supplement (twice daily for 10 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (twice daily for 10 weeks)
Number of subjects: 53
Study: 10027431

Group type: EXPERIMENTAL
Intervention: Infused Ang II at 1 ng/kg/min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Infused Ang II at 2 ng/kg/min
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Infused Ang II at 1 ng/kg/min and 2 ng/kg/min
Number of subjects: 8
Study: 8643170

Group type: EXPERIMENTAL
Intervention: High-dose iron therapy (100 mg at the end of HD treatment)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Low-dose iron therapy (10, 20, or 40 mg per HD depending on haemoglobin, serum ferritin, and transferrin saturation)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intravenous rHuEpo therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Subcutaneous rHuEpo therapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Withdrawal of iron administration
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: rHuEpo therapy in well-nourished patients (serum albumin > 40 g/l) without hyperparathyroidism
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: rHuEpo therapy in patients with hyperparathyroidism
Number of subjects: 64
Study: 2298365

Group type: EXPERIMENTAL
Intervention: Aspirin administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 0
Study: 7014392

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 136

Group type: COMPARATOR
Intervention: No additional therapy (control)
Number of subjects: 136
Study: 27762041

Group type: EXPERIMENTAL
Intervention: Acute free-weight resistance exercise (ARE)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Quiet control (CON)
Number of subjects: 15
Study: 27406639

Group type: EXPERIMENTAL
Intervention: Antenatal integrative medicine education programme plus standard care
Number of subjects: 176

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 176
Study: 23432666

Group type: EXPERIMENTAL
Intervention: Modified polylactide/polyglycolide acid (PLGA) test membrane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Expanded polytetrafluorethylene (ePTFE) control membrane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both membranes
Number of subjects: 40
Study: 22143925

Group type: EXPERIMENTAL
Intervention: Intraarticular injection of gadopentetate dimeglumine, ropivacaine 0.5%, and normal saline (group A)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Intraarticular injection of gadopentetate dimeglumine and normal saline (group B)
Number of subjects: 127
Study: 20167989

Group type: EXPERIMENTAL
Intervention: Guidelines plus CHD risk profiles
Number of subjects: 3266

Group type: COMPARATOR
Intervention: Guidelines alone
Number of subjects: 3266
Study: 18765509

Group type: EXPERIMENTAL
Intervention: Asoprisnil 10 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Asoprisnil 25 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 16126397

Group type: EXPERIMENTAL
Intervention: Superiorly based masseter muscle flap
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Island masseter muscle flap
Number of subjects: 22
Study: 14652471

Group type: EXPERIMENTAL
Intervention: Fear-avoidance-based physical therapy (n = 34)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard care physical therapy (n = 32)
Number of subjects: 66
Study: 11126105

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8866803

Group type: EXPERIMENTAL
Intervention: Five-valent pneumococcal conjugate vaccine (3 doses of 5 micrograms of types 6B, 14, 18, 19F, and 23F polysaccharides conjugated to CRM197)
Number of subjects: 90

Group type: COMPARATOR
Intervention: H. influenzae type b vaccine (2 doses)
Number of subjects: 90
Study: 1632567

Group type: EXPERIMENTAL
Intervention: Captopril (12.5 to 50 mg three times a day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nadolol (20 to 160 mg once a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6436700

Group type: EXPERIMENTAL
Intervention: Leuprolide (1 mg subcutaneously daily)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Diethylstilbestrol (DES, 3 mg by mouth daily)
Number of subjects: 199
Study: 30306884

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (conversion over 22-33 days)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (conversion over 1-7 days)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (conversion over 8-14 days)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (conversion over 15-21 days)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Brexpiprazole (all conversion groups)
Number of subjects: 404
Study: 29980460

Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 26556391

Group type: EXPERIMENTAL
Intervention: Flexible knee support (brace)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No brace (control)
Number of subjects: 108
Study: 24633138

Group type: EXPERIMENTAL
Intervention: Saccadic eye movement training with visual scanning exercises (VSEs) integrated with task-specific activities
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (task-specific activities only)
Number of subjects: 24
Study: 22395644

Group type: EXPERIMENTAL
Intervention: Tamoxifen monotherapy
Number of subjects: 4861

Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment
Number of subjects: 4861
Study: 20083693

Group type: EXPERIMENTAL
Intervention: pimecrolimus, 1%, cream
Number of subjects: 3
Study: 18274206

Group type: EXPERIMENTAL
Intervention: Tyrosine (12g mixed in 113g applesauce)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Combined levothyroxine (50 microg) and liothyronine (12.5 microg) supplement
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 15857745

Group type: EXPERIMENTAL
Intervention: Corticosteroids for symptom palliation in intestinal obstruction
Number of subjects: 29

Group type: COMPARATOR
Intervention: Normal adrenal function (Group 1)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Adrenal insufficiency (Group 2)
Number of subjects: 29
Study: 12172280

Group type: EXPERIMENTAL
Intervention: Antiglide plating
Number of subjects: 193

Group type: COMPARATOR
Intervention: Lateral plating
Number of subjects: 193
Study: 9539578

Group type: EXPERIMENTAL
Intervention: Interstitial thermometry during hyperthermia treatment
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Interstitial thermometry
Number of subjects: 215
Study: 7595819

Group type: EXPERIMENTAL
Intervention: Information and coping skills training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine information provision (Control)
Number of subjects: 48
Study: 2695860

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy with adjuvant Glipressina
Number of subjects: 20

Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy without adjuvant Glipressina
Number of subjects: 20
Study: 1275989

Group type: EXPERIMENTAL
Intervention: Dobutamine (1.25-10 mug/kg per min)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Isoprenaline (0.005-0.04 mug/kg per min)
Number of subjects: 11
Study: 31335198

Group type: EXPERIMENTAL
Intervention: Patient-led titration of insulin glargine 100 U/mL
Number of subjects: 75

Group type: COMPARATOR
Intervention: Physician-led titration of insulin glargine 100 U/mL
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study: 28538261

Group type: EXPERIMENTAL
Intervention: Better Exercise Adherence after Treatment for Cancer (BEAT Cancer)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study: 26541350

Group type: EXPERIMENTAL
Intervention: Steroid group (0.5 mg/kg intravenous methylprednisolone for 2 days followed by 12 mg daily oral methylprednisolone for 4 days)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (no steroid therapy)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Steroid group
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 138
Study: 23151649

Group type: EXPERIMENTAL
Intervention: Pelvic radiotherapy (RT)
Number of subjects: 125
Study: 17109580

Group type: EXPERIMENTAL
Intervention: Probiotic capsules containing Lactobacillus acidophilus and Bifidobacterium longum
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 31
Study: 15193361

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of pigment epithelium-derived factor (PEDF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of PEDF
Number of subjects: 0
Study: 10939775

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Homeopathic or conventional treatment according to patient preference
Number of subjects: 2400
Study: 8622602

Group type: EXPERIMENTAL
Intervention: Acipimox (ACX) 500 mg (one dose)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Acipimox (ACX) for 1 month
Number of subjects: 13

Group type: COMPARATOR
Intervention: GHRH (1-29) 1 microg/kg IV
Number of subjects: 13

Group type: COMPARATOR
Intervention: Baseline FFA levels
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: One-dose ACX (500 mg)
Number of subjects: 13
Study: 1533478

Group type: EXPERIMENTAL
Intervention: Plasma-derived vaccine (Green Cross HB-vaccine)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Yeast-derived recombinant vaccine (Engerix B)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combination of plasma-derived and yeast-derived vaccines
Number of subjects: 58
Study: 3967053

Group type: EXPERIMENTAL
Intervention: Patch
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Screen
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 31071612

Group type: EXPERIMENTAL
Intervention: Self-Controlled (SC) feedback
Number of subjects: 42

Group type: COMPARATOR
Intervention: Yoked (YK) feedback
Number of subjects: 42
Study: 28366818

Group type: EXPERIMENTAL
Intervention: Adjunctive photodynamic therapy (PDT) with scaling and root debridement
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (scaling and root debridement alone)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Adjunctive photodynamic therapy (PDT)
Number of subjects: 27
Study: 26234986

Group type: EXPERIMENTAL
Intervention: High anxiety levels (47.8%)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: High depression levels (38.2%)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Family status, educational level, number of children, adherence to doctors' orders, proposed diet, relations with healthcare professionals and other patients
Number of subjects: 395
Study: 23665342

Group type: EXPERIMENTAL
Intervention: 800 IU of vitamin D3 per day (low dose)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4,370 IU of vitamin D3 per day (high dose)
Number of subjects: 40
Study: 21204680

Group type: EXPERIMENTAL
Intervention: CAD+G (computer-assisted dieting plus self-management training)
Number of subjects: 55

Group type: COMPARATOR
Intervention: CAD-only (computer-assisted dieting only)
Number of subjects: 55
Study: 19643917

Group type: EXPERIMENTAL
Intervention: Clinical fMRI overt language design with semantic and syntactic error‐detection tasks
Number of subjects: 30
Study: 19681255

Group type: EXPERIMENTAL
Intervention: 6% hydrogen peroxide whitening strips (Crest Whitestrips)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 19% sodium percarbonate brush-applied gel (Crest Night Effects)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo brush-applied gel without peroxide
Number of subjects: 72
Study: 15186865

Group type: EXPERIMENTAL
Intervention: 5-day teaching program for diabetic patients
Number of subjects: 319

Group type: COMPARATOR
Intervention: Control group of 241 insulin-treated patients
Number of subjects: 319
Study: 11769568

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham-smoking
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nonsmokers' group
Number of subjects: 48
Study: 9744782

Group type: EXPERIMENTAL
Intervention: Electrical stimulation for stress urinary incontinence
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Electrical stimulation for urge urinary incontinence
Number of subjects: 10
Study: 8046692

Group type: EXPERIMENTAL
Intervention: $5 financial incentive
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: $10 financial incentive
Number of subjects: 517

Group type: COMPARATOR
Intervention: Early responders
Number of subjects: 517

Group type: COMPARATOR
Intervention: Late responders
Number of subjects: 517
Study: 2494686

Group type: EXPERIMENTAL
Intervention: Lithium carbonate therapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 30921183

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard uncoated balloon
Number of subjects: 111
Study: 28422526

Group type: EXPERIMENTAL
Intervention: Acupuncture group (AG)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham acupuncture group (CG)
Number of subjects: 59
Study: 26308684

Group type: EXPERIMENTAL
Intervention: Combination therapy with 10 mg of ambrisentan plus 40 mg of tadalafil
Number of subjects: 500

Group type: COMPARATOR
Intervention: Ambrisentan monotherapy (10 mg)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Tadalafil monotherapy (40 mg)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 500
Study: 23038021

Group type: EXPERIMENTAL
Intervention: Powdered black tea solids containing 429 mg of polyphenols
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control product matched in flavour and caffeine content but containing no tea solids
Number of subjects: 111
Study: 22045080

Group type: EXPERIMENTAL
Intervention: Low-dose adenosine (24 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-dose adenosine (36 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Adenosine (both doses)
Number of subjects: 20